Loading the Newsroom

More than 30 cornerstone investors have already signed up, setting up a potential Hong Kong mega-listing driven by AI optical demand.

The newborn-brain-injury biotech is betting on Hong Kong capital markets before a later US secondary listing.

The former Google China chief says 01.ai is also unwinding offshore structure, clearing a path for listing.